NEW YORK ( TheStreet) -- Shares of Neoprobe Corporation (AMEX: NEOP) were gapping up Thursday morning with an open price 10.7% higher than Wednesday's closing price. The stock closed at $2.98 Wednesday and opened today's trading at $3.30. The average volume for Neoprobe has been 1.1 million shares per day over the past 30 days. Neoprobe has a market cap of $270.8 million and is part of the health care sector and health services industry. Shares are up 38.8% year to date as of the close of trading on Wednesday. Neoprobe Corporation, a biomedical company, engages in the development and commercialization of surgical and diagnostic oncology products that enhance patient treatment by meeting the critical decision making needs of physicians in the United States and internationally. TheStreet Ratings rates Neoprobe as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. You can view the full Neoprobe Ratings Report. Get more investment ideas from our investment research center. Interested in other stocks that are gapping up? Get free SMS text alerts sent to you when the action happens by texting UP to 95370 or select from multiple alert options.
More from Markets
3 Earnings Reports Will Be Key for the Market Next Week
There is a good foundation for more positive action in the week ahead.
Stocks Finish Lower, Pulled Down by Boeing, Johnson & Johnson, Weak China Growth
Stocks declined as Boeing and Johnson & Johnson pulled shares down, while China posted its weakest quarterly economic growth rate in nearly three decades, returning investors' attention to the trade talks between Washington and Beijing.
Are Stock Investors Overreacting to China's GDP Lag? One Big Investor Thinks So
Stock investors should take a finer look at China's economy, UBS thinks.